These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
640 related articles for article (PubMed ID: 16548490)
1. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo]. Pitche P; Mouzou T; Padonou C; Tchangai-Walla K Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490 [TBL] [Abstract][Full Text] [Related]
2. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases]. Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593 [TBL] [Abstract][Full Text] [Related]
3. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601 [TBL] [Abstract][Full Text] [Related]
4. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania. Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179 [TBL] [Abstract][Full Text] [Related]
5. [Stevens-Johnson syndrome and toxic epidermal necrolysis in Lomé (Togo). Evolutional and etiological profiles of 40 cases]. Pitché P; Padonou CS; Kombate K; Mouzou T; Tchangai-Walla K Ann Dermatol Venereol; 2005; 132(6-7 Pt 1):531-4. PubMed ID: 16142100 [TBL] [Abstract][Full Text] [Related]
6. Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study. Kannenberg SM; Jordaan HF; Koegelenberg CF; Von Groote-Bidlingmaier F; Visser WI QJM; 2012 Sep; 105(9):839-46. PubMed ID: 22543685 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of cutaneous drug eruptions in adult Nigerians with HIV/AIDS. Salami TA; Asalu AF; Samuel SO Niger Postgrad Med J; 2010 Jun; 17(2):160-3. PubMed ID: 20539333 [TBL] [Abstract][Full Text] [Related]
8. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Yang Y; Xu J; Li F; Zhu X Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis]. Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835 [TBL] [Abstract][Full Text] [Related]
10. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon. Kuaban C; Bercion R; Koulla-Shiro S East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410 [TBL] [Abstract][Full Text] [Related]
11. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases. Chen J; Wang B; Zeng Y; Xu H Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352 [TBL] [Abstract][Full Text] [Related]
12. Severe cutaneous adverse reactions due to isoniazid in a HIV positive patient. Viswanath BK; Ranka P; Ramanjanayalu M Indian J Lepr; 2012; 84(3):227-32. PubMed ID: 23484337 [TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations. Teraki Y; Shibuya M; Izaki S Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350 [TBL] [Abstract][Full Text] [Related]
14. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462 [TBL] [Abstract][Full Text] [Related]
15. [Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk]. Gómez-Criado MS; Ayani I; León-Colombo T; Ramos ML; Reneses MJ Rev Neurol; 2004 Jun 1-15; 38(11):1056-60. PubMed ID: 15202085 [TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management. Sane SP; Bhatt AD J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928 [TBL] [Abstract][Full Text] [Related]
17. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC; J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772 [TBL] [Abstract][Full Text] [Related]
18. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Lonjou C; Borot N; Sekula P; Ledger N; Thomas L; Halevy S; Naldi L; Bouwes-Bavinck JN; Sidoroff A; de Toma C; Schumacher M; Roujeau JC; Hovnanian A; Mockenhaupt M; Pharmacogenet Genomics; 2008 Feb; 18(2):99-107. PubMed ID: 18192896 [TBL] [Abstract][Full Text] [Related]
19. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole. Wanat KA; Anadkat MJ; Klekotka PA J Am Acad Dermatol; 2009 Apr; 60(4):589-94. PubMed ID: 19217690 [TBL] [Abstract][Full Text] [Related]
20. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]